{Reference Type}: Journal Article
{Title}: Induction of DEPP1 by HIF Mediates Multiple Hallmarks of Ischemic Cardiomyopathy.
{Author}: Wyant GA;Jiang Q;Singh M;Qayyum S;Levrero C;Maron BA;Kaelin WG;
{Journal}: Circulation
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jun 17
{Factor}: 39.918
{DOI}: 10.1161/CIRCULATIONAHA.123.066628
{Abstract}: UNASSIGNED: HIF (hypoxia inducible factor) regulates many aspects of cardiac function. We and others previously showed that chronic HIF activation in the heart in mouse models phenocopies multiple features of ischemic cardiomyopathy in humans, including mitochondrial loss, lipid accumulation, and systolic cardiac dysfunction. In some settings, HIF also causes the loss of peroxisomes. How, mechanistically, HIF promotes cardiac dysfunction is an open question.
UNASSIGNED: We used mice lacking cardiac pVHL (von Hippel-Lindau protein) to investigate how chronic HIF activation causes multiple features of ischemic cardiomyopathy, such as autophagy induction and lipid accumulation. We performed immunoblot assays, RNA sequencing, mitochondrial and peroxisomal autophagy flux measurements, and live cell imaging on hearts and isolated cardiomyocytes. We used CRISPR-Cas9 gene editing in mice to validate a novel mediator of cardiac dysfunction in the setting of chronic HIF activation.
UNASSIGNED: We identify a previously unknown pathway by which cardiac HIF activation promotes the loss of mitochondria and peroxisomes. We found that DEPP1 (decidual protein induced by progesterone 1) is induced under hypoxia in a HIF-dependent manner and localizes inside mitochondria. DEPP1 is both necessary and sufficient for hypoxia-induced autophagy and triglyceride accumulation in cardiomyocytes ex vivo. DEPP1 loss increases cardiomyocyte survival in the setting of chronic HIF activation ex vivo, and whole-body Depp1 loss decreases cardiac dysfunction in hearts with chronic HIF activation caused by VHL loss in vivo.
UNASSIGNED: Our findings identify DEPP1 as a key component in the cardiac remodeling that occurs with chronic ischemia.